Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (591-600 of 1,058) with videos related to

Pageof 106
Sort By:
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Leukemia Research|May 31, 2022
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemiaSwagata Goswami, Chi-Ling Chiang, Kevan Zapolnik, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapyNeil E Kay, Jeanette E Eckel-Passow, Esteban Braggio, et al.
Leukemia|February 1, 2012
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic featuresJ A Woyach, G Lozanski, A S Ruppert, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 27, 2007
Liquid chromatography mass spectrometry profiling of histonesXiaodan Su, Naduparambil K Jacob, Ravindra Amunugama, et al.
Molecular Biosystems|October 9, 2012
Elucidating role of salivary proteins in denture stomatitis using a proteomic approachSompop Bencharit, Sandra K Altarawneh, Sarah Schwartz Baxter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Blood|November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLShih-Shih Chen, Rainer Claus, David M Lucas, et al.
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Pageof 106

Showing results (591-600 of 1,058) with videos related to

Sort By:
Pageof 106
Leukemia|October 22, 2005
The evolving role of alemtuzumab in management of patients with CLLS Faderl, S Coutré, J C Byrd, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 28, 2022
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In VivoChristopher R Lucas, Patrick D Halley, Amjad A Chowdury, et al.
Leukemia Research|May 31, 2022
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemiaSwagata Goswami, Chi-Ling Chiang, Kevan Zapolnik, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapyNeil E Kay, Jeanette E Eckel-Passow, Esteban Braggio, et al.
Leukemia|February 1, 2012
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic featuresJ A Woyach, G Lozanski, A S Ruppert, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 27, 2007
Liquid chromatography mass spectrometry profiling of histonesXiaodan Su, Naduparambil K Jacob, Ravindra Amunugama, et al.
Molecular Biosystems|October 9, 2012
Elucidating role of salivary proteins in denture stomatitis using a proteomic approachSompop Bencharit, Sandra K Altarawneh, Sarah Schwartz Baxter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Blood|November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLLShih-Shih Chen, Rainer Claus, David M Lucas, et al.
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Pageof 106